To examine whether BAFF plays a role in GVHD, we compared serum BAFF levels between five patients with systemic high-dose chemotherapy alone and four patients with acute GVHD (overall grade III or IV) after allo-HSCT. The gene discussed is TNFSF13B; the disease is graft versus host disease.